By Editor , 18 September 2026
Alibaba-Backed Orange Lion Sports Launches Smartshot 2.0 with AI Line Calling

Beijing – September 17, 2026 -- Orange Lion Sports, a company founded by Alibaba Group, unveiled Smartshot 2.0, an upgraded AI sports technology platform, at the Sports Services exhibition during the 2026 China International Fair for Trade in Services (CIFTIS), held September 9-13 in Beijing.

By Editor , 18 September 2026
DongCheng Group Unveils New Power Tool Lines Across Three Brands

Shanghai – September 17, 2026 -- DongCheng Company held separate global online product launch events in August for its three power tool brands -- DongCheng, DCA and DCK -- unveiling new lineups spanning construction, metalworking, woodworking and home renovation applications.

By Editor , 18 September 2026
Shanghai Electric H1 Revenue Jumps 16.6% on CNY100.4bn Order Book

Shanghai – September 17, 2026 -- Shanghai Electric posted operating revenue of CNY 63.332 billion (USD 9.17 billion) in the first half of 2026, up 16.6% year-on-year, while net profit attributable to shareholders rose 18.2% to CNY 970 million (USD 140.49 million). New orders reached CNY 100.39 billion (USD 14.54 billion), extending the company's order backlog across energy equipment, industrial equipment and integrated services.

By Editor , 18 September 2026

Shanghai – September 17, 2026 -- MoleculeMind, an AI-native bioengineering infrastructure company, has had research on its reactive atomistic modeling platform QuantaMind published in Science Advances, demonstrating Density Functional Theory (DFT)-level accuracy in simulating 10,000-atom biomolecular systems over tens-of-nanosecond timescales.

By Editor , 18 September 2026

Beijing – September 17, 2026 -- A 4-meter hydraulic-electric hybrid humanoid robot capable of carrying a 500 kg dual-arm payload while maintaining fingertip repeatability of ±0.05 mm has been unveiled by Beijing-based NeodraDynamics Robotics at the World Robot Conference (WRC) in Beijing. The machine, named Neo1, combines digital hydraulics with electric actuation, a pairing the company says eliminates the industry's long-standing trade-off between raw force and fine motor precision.

By Editor , 17 September 2026
Kelun-Biotech's HER2 ADC Beats T-DM1 in Phase III, Wins China Approval

Chengdu – September 16, 2026 -- Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (6990.HK) said phase III results for its HER2-targeted antibody-drug conjugate trastuzumab botidotin have been published in the Journal of Clinical Oncology, a journal with an impact factor of 44.7, after the drug outperformed Roche's trastuzumab emtansine (T-DM1) in a head-to-head trial and secured approval from China's National Medical Products Administration.

By Editor , 17 September 2026
Antengene Data Show CD73 Inhibitor Boosts Selinexor Efficacy in Myeloma

Shanghai and Hong Kong – September 16, 2026 -- Antengene Corporation Limited (SEHK: 6996.HK) has published preclinical data showing that combining its CD73 inhibitor ATG-037 with selinexor suppressed tumor growth by 62% in a multiple myeloma mouse model, versus 31% for ATG-037 alone and 43% for selinexor alone. The peer-reviewed paper, developed with the Department of Hematology at Peking University Third Hospital, appears in Cancer Gene Therapy, an SCI journal under Springer Nature (DOI: 10.1038/s41417-026-01078-9).